Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs

Clinical and Experimental Metastasis

Volumn 14, Issue 3, 1996, Pages 253-267

  Glinsky, Gennadi V ^a,c   Mossine, Valeri V ^c   Price, Janet E ^b   Bielenberg, Diane ^b   Glinsky, Vladislav V ^a   Ananthaswamy, Honnavara N ^b   Feather, Milton S ^c  

^a Cancer Research Center   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c University of Missouri   (United States)

Author keywords

Amadori compounds; Clonogenic growth; Metastasis; Synthetic glycoamines

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN; N (1 DEOXYFRUCTOS 1 YL) DEXTRO LEUCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELL AGGREGATION; CLONOGENESIS; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; TUMOR GROWTH;

AMINO SUGARS; ANIMALS; BINDING, COMPETITIVE; BREAST NEOPLASMS; CARBOHYDRATE SEQUENCE; CARCINOMA; COLONY-FORMING UNITS ASSAY; FEMALE; GALACTOSIDES; GLUCOSAMINE; HUMANS; LECTINS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MELANOMA; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEOPLASM METASTASIS; SEPHAROSE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0030017726     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Smets LA, 1989, Cell transformation as a model for tumor induction and neoplastic growth. Biochim Biophvs Acta, 605, 93-111.
2. Von Hoff DD, Clark GM, Stogdill BJ et al, 1983, Prospective clinical trial of a human tumor cloning system. Cancer Res, 43, 1926-31.
3. Nomura Y, Tashiro H and Hisamatsu K, 1990, Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar. J Natl Cancer Inst, 82, 1146-9.
4. Hug V, Rashid R, Johnston D et al, 1987, Clonogenic growth and hormone sensitivity of benign and malignant breast tissues. Br J Cancer, 56, 619-21.
5. Nomura Y, Tashiro H and Hisamatsu K, 1989, In vitro clonogenic growth and metastatic potential of human operable breast cancer. Cancer Res, 49, 5288-93.
6. Cifone MA and Fidler IJ, 1980, Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA, 77, 1039-43.
7. Price JE, 1986, Clonogenicity and experimental metastatic potential of spontaneous mouse mammary neoplasms. J Natl Cancer Inst, 77, 529-35.
8. Saiga T, Kashu I, Tabuchi K et al, 1989, Increased contraenvironmental pressure division capability: a decisive force in metastasis and invasion of mouse lung adenocarcinoma cell lines. Invasion Metastasis, 9, 254-68.
9. Fidler IJ, Li L, Ananthaswamy H et al, 1991, Correlation of growth capacity in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Anticancer Res, 11, 17-24.
10. Li L, Price JE, Fan D, Zhang RD, Bucana CD and Fidler IJ, 1989, Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst, 81, 1406-12.
11. Zhang RD, Fidler IJ and Price JE, 1991, Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis, 11, 204-15.
12. Zhang RD, Price JE, Schackert G, Itoh K and Fidler IJ, 1991, Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Cancer Res, 51, 2029-35.
13. Glinsky GV, 1989, Glycoamines: biochemistry of a new class of humoral tumor markers. J Tumor Markers Oncol, 4, 193-221.
14. Glinsky GV, 1992, Glycoamines: structural-functional characterization of a new class of humoral tumor markers. In: Sell S, ed. Serological Cancer Markers. Totowa, NJ: The Humana Press, pp. 233-60.
15. Kuo KC, Gehrke JC, Allen WC et al, 1994, High-performance liquid Chromatographic analysis of glycoamines in serum. J Chromatogr, 656, 295-302.
16. Glinsky GV, Linetsky MD, Shemyakin VV, Markin VV, Liventsov VV and Ivanova AB, 1990, Structural analysis of a new class of humoral tumor markers: characterization of 48 aminoglycoconjugates (glycoamines) isolated from rat and human blood plasma. J Tumor Marker Oncol, 5, 107-18.
17. Glinsky GV and Linetsky MD, 1990, Structural analysis of the carbohydrate core of amino-glycoconjugates (glycoamines) from blood plasma of oncological patients. J Tumor Marker Oncol, 5, 137-60.
18. Glinsky GV, Linetsky MD, Liventsov VV et al, 1990, Glycoamine-synthesizing reaction: molecular mechanism of the incorporation of monomers into aminoglycoconjugates. J Tumor Marker Oncol, 5, 119-36.
19. Glinsky GV, 1993, Cell adhesion and metastasis: is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Crit Rev Oncol/Hematol, 14, 229-78.
20. Glinsky GV, 1993, Glycodeterminants of melanoma cell adhesion. A model for antimetastatic drugs design. Crit Rev Oncol/Hematol, 14, 1-13.
21. Glinsky GV, 1992, The blood group antigen-related glycoepitopes: biological functions and implications in immunogenesis, cancer, and AIDS pathogenesis. The Medical Intelligence Units, RG Landes Co., Austin, TX.
22. Glinsky GV, 1992, The blood group antigens (BGA)-related glycoepitopes. A key structural determinant in immunogenesis and cancer pathogenesis. Crit Rev Oncol/Hematol, 12, 151-66.
23. Linetsky MD, Semenova-Kobzar RA and Glinsky GV, 1991, The modifying influence of endogenous biopolymers, glycoamines, from the blood serum of BALB/C mice on aggregation properties of experimental rhabdomyosarcoma cells. Expl Oncol, 13, 27-33.
24. Mossine VV, Glinsky GV and Feather MS, 1994, The preparation and characterization of some Amadori compounds (1-amino-1-deoxy-D-fructose derivatives) derived from a series of aliphatic ω-amino acids. Carbohydrate Res, 262, 257-70.
25. Mossine VV, Glinsky GV, Barnes ChL and Feather MS, 1995, Crystal structure of an Amadori compound, N-(1-Deoxy-β-D-fructopyranos-1-yl)-glycine ("D-fructose-glycine"). Carbohydrate Res, 266, 5-14.
26. Price JE, Polyzos A, Zhang RD and Daniels LM, 1990, Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res, 50, 717-21.
27. Fidler IJ, 1973, The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer, 9, 223-7.
28. Fidler IJ, 1973, Selection of successive tumor lines for metastasis. Nat New Biol, 242, 148-9.
29. Fidler IJ, 1975, Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res, 35, 218-24.
30. Hart IR, 1979, The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol, 97, 587-92.
31. Meromsky L, Lotan R and Raz A, 1986, Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res, 46, 5270-5.
32. Nicolson GL, 1982, Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta, 695, 113-76.
33. Nicolson GL, 1984, Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity. Expl Cell Res, 150, 3-22.
34. Roos E, 1984, Cellular adhesion, invasion and metastasis. Biochim Biophys Acta, 738, 263-84.
35. Glaves D, 1983, Correlation between circulating cancer cells and incidence of metastases. Br J Cancer, 48, 665-73.
36. Liotta LA, Kleinerman J and Saidel GM, 1976, The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res, 36, 889-94.
37. Varani J, Orr W and Ward PA, 1980, Adhesive characteristics of tumor cell variant of high and low tumorigenic potential. J Natl Cancer Inst, 64, 1173-8.
38. Winkelhake JL and Nicolson GL, 1976, Determination of adhesive properties of variant metastatic melanoma cells to BALB/3T3 cells and their virus-transformed derivatives by a monolayer attachment assay. J Natl Cancer Inst, 56, 285-91.
39. Nicolson GL, Brunson KW and Fidler IJ, 1978, Specificity of arrest, survival, and growth of selected metastatic variant cell lines. Cancer Res, 38, 4105-11.
40. Fidler IJ and Bucana C, 1977, Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res, 37, 3945-56.
41. Gasic GL, Gasic TB, Galanti N, Johnson T and Murphy S, 1973, Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer, 11, 704-18.
42. Raz A, Bucana C, McLellan W and Fidler IJ, 1980, Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential. Nature, 284, 363-4.
43. Nicolson GL and Winkelhake JL, 1975, Organ specificity of blood-borne tumor metastasis determined by cell adhesion? Nature, 255, 230-2.
44. Lotan R and Raz A, 1983, Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation. Cancer Res, 43, 2088-93.
45. Lotan R, Lotan D and Raz A, 1985, Inhibition of tumor cell colony formation in culture by a monoclonal antibody to endogenous lectins. Cancer Res, 45, 4349-53.
46. Lotan R, Cavvalero D, Lotan D and Raz A, 1989, Biochemical and immunological characterization of K-1735P melanoma galactoside-binding lectins and their modulation by differentiation inducers. Cancer Res, 49, 1261-8.
47. Raz A and Lotan R, 1981, Lectin-like activities associated with human and murine neoplastic cells. Cancer Res. 41, 3642-7.
48. Allen HJ, Karakousis C, Piver MS et al, 1987, Galactoside-binding lectin in human tissues. Tumor Biol, 8, 218-29.
49. Carding SR, Thorpe SJ, Thorpe R and Feizi T, 1985, Transformation and growth related changes in levels of nuclear and cytoplasmic proteins antigenically related to mammalian ß-galactoside-binding lectin. Biochem Biophys Res Commun, 127, 680-6.
50. Gabius H-J, Engelhardt R and Cramer F, 1986, Endogenous tumor lectins: overview and perspectives. Anticancer Res, 6, 573-8.
51. Gitt MA and Barondes SH, 1986, Evidence that a human soluble ß-galactoside-binding lectin is encoded by a family of genes. Proc Natl Acad Sci USA, 83, 7603-7.
52. Raz A, Meromsky L, Carmi P, Karakash R, Lotan D and Lotan R, 1984, Monoclonal antibodies to endogenous galactoside-specific tumor cell lectins. EMBO J, 3, 2979-83.
53. Raz A, Meromsky L and Lotan R, 1986, Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells. Cancer Res, 46, 3667-72.
54. Raz A, Avivi A, Pazarini G and Garmi P, 1987, Cloning and expression of cDNA for two endogenous UV-2237 fibrosarcoma lectin genes. Exp Cell Res, 173, 109-16.
55. Raz A, Meromsky L, Zvibel I and Lotan R, 1987, Transformation-related changes in the expression of endogenous cell lectins. Int J Cancer, 39, 353- 60.
56. Raz A, Carmi P and Pazarini, G, 1988, Expression of two different endogenous galactoside-binding lectins sharing sequence homology. Cancer Res, 48, 645-9.
57. Weis WI, 1994, Recognition of cell surface carbohydrates by C-type animal lectins. In: Metcalf BW, Dalton BJ and Poste G, eds. Cellular Adhesion: molecular definition to therapeutic potential. New York: Plenum Press, pp. 55-75.
58. Springer GF, 1984, T and Tn, general carcinoma autoantigens. Science, 224, 1198-206.
59. Wu V-Y and Cohen P, 1994, Receptors specific for Amadori-modified glycated albumin on murine endo-thelial cells. Biochem Biophys Res Commun, 198, 734-9.
60. Stein R, Chen S, Grossman W and Goldenberg DM, 1989, Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res, 49, 32-7.
61. Gluzman DF, Abramenko IB, Sklyarenko LM and Pisnyachevskaya GV, 1993. Immunocytochemicial Diagnosis of the Malignant Serous Effusions. Kiev: Naukova Dumka.
62. Springer GF, Cheinsong-Popov R, Schirrmacher V, Desoi PR and Tegtmeyer H, 1983, Proposed molecular basis of murine tumor cell hepatocyte interaction. J Biol Chem, 258, 5702-6.
63. Lee RT, Lin P and Lee YuCh, 1984, New synthetic cluster ligands for galactose/N-acetylgalactosamine-specific lectin of mammalian liver. Biochemistry, 23, 4225-61.
64. Ruoslahti E and Reed J, 1994, Anchorage dependence, integrins, and apoptosis. Cell, 77, 477-8.
65. Boudreau N, Sympson CJ, Werb Z and Bissell MJ, 1995, Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science, 267, 891-3.
66. Frisch SM and Francis H, 1994, Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124, 619-26.
67. Meredith JE, Fazeli B and Schwartz MA, 1994, The extracellular matrix as a cell survival factor. Mol Biol Cell, 4, 953-61.
68. b3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 1157-64.
69. Glinsky GV and Glinsky VV, 1996, Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett (in press).
70. Hakomori S-I, 1991, Possible functions of tumorassociated carbohydrate antigens. Curr Opinion Immunol, 3, 646-53.
71. Hakomori S-I, 1991, Possible new directions in cancer therapy based on aberrant expression of glycosphingo-lipids: anti-adhesion and ortho-signaling therapy. Cancer Cells, 3, 461-70.
72. Woynarowska B, Skrincosky DM, Haag A, Sharma M, Matta K and Bernacki RJ, 1994, Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs. J Biol Chem, 269, 22797-803.
73. Pienta KJ, Naik H, Akhtar A et al, 1995, Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst, 87, 348-53.